2021 Y Combinator alum MindState Design Labs left stealth Thursday with $11.5 million in funding to develop psychedelics-based therapy drugs. Psychedelics, long stigmatized as risky recreational drugs, are finally finding a place in polite society. More and more research from prominent institutions such as Johns Hopkins suggests that such drugs, in the right formulations and with supervision, can bring about therapeutic breakthroughs in patients, notably in those that have proven to be resistan...
2021 Y Combinator alum MindState Design Labs left stealth Thursday with $11.5 million in funding to develop psychedelics-based therapy drugs. Psychedelics, long stigmatized as risky recreational drugs, are finally finding a place in polite society. More and more research from prominent institutions such as Johns Hopkins suggests that such drugs, in the right formulations and with supervision, can bring about therapeutic breakthroughs in patients, notably in those that have proven to be resistan...
Share this Article
Recommended